FI943422A0 - Menetelmä sytolyyttisen T-solujen prekursorien määrittämiseksi - Google Patents

Menetelmä sytolyyttisen T-solujen prekursorien määrittämiseksi

Info

Publication number
FI943422A0
FI943422A0 FI943422A FI943422A FI943422A0 FI 943422 A0 FI943422 A0 FI 943422A0 FI 943422 A FI943422 A FI 943422A FI 943422 A FI943422 A FI 943422A FI 943422 A0 FI943422 A0 FI 943422A0
Authority
FI
Finland
Prior art keywords
cytolytic
determination
cell precursors
precursors
cell
Prior art date
Application number
FI943422A
Other languages
English (en)
Swedish (sv)
Other versions
FI943422A (fi
Inventor
Pierre G Coulie
Thierry Boon
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of FI943422A publication Critical patent/FI943422A/fi
Publication of FI943422A0 publication Critical patent/FI943422A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
FI943422A 1992-01-21 1994-07-19 Menetelmä sytolyyttisen T-solujen prekursorien määrittämiseksi FI943422A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82393392A 1992-01-21 1992-01-21
PCT/US1993/000083 WO1993014189A1 (en) 1992-01-21 1993-01-07 Method for determining cytolytic t cell precursors

Publications (2)

Publication Number Publication Date
FI943422A FI943422A (fi) 1994-07-19
FI943422A0 true FI943422A0 (fi) 1994-07-19

Family

ID=25240169

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943422A FI943422A0 (fi) 1992-01-21 1994-07-19 Menetelmä sytolyyttisen T-solujen prekursorien määrittämiseksi

Country Status (8)

Country Link
EP (1) EP0624189A4 (fi)
JP (1) JPH07503134A (fi)
KR (1) KR950700402A (fi)
AU (1) AU3435293A (fi)
CA (1) CA2128424A1 (fi)
FI (1) FI943422A0 (fi)
NO (1) NO942660L (fi)
WO (1) WO1993014189A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100261856B1 (ko) * 1991-05-23 2000-07-15 에드워드 에이. 맥더모 2세, 로이드 제이. 오울드 종양 거부 항원 전구체, 종양 거부 항원 및 그 용도
US6352826B1 (en) 1991-11-25 2002-03-05 Yoreh Biotechnologies, Ltd. Method and kit for the detection of retroviral specific antibodies in seronegative individuals
US6280962B1 (en) 1991-11-25 2001-08-28 Yoreh Biotechnologies Ltd. Whole blood/mitogen assay for the early detection of a subject with cancer and kit
US6322989B1 (en) 1991-11-25 2001-11-27 Yoreh Biotechnologies, Ltd. Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
US5874560A (en) * 1994-04-22 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Melanoma antigens and their use in diagnostic and therapeutic methods
CA2188432C (en) 1994-04-22 2011-02-01 Yutaka Kawakami Melanoma antigens
US5843648A (en) * 1995-01-10 1998-12-01 The United States Of America As Represented By The Secretary, Department Of Health And Human Services P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
US6951917B1 (en) 1995-09-26 2005-10-04 The United States Of America As Represented By The Department Of Health And Human Services MHC-class II restricted melanoma antigens and their use in therapeutic methods
US7501501B2 (en) 1995-09-26 2009-03-10 The United States Of America As Represented By The Secretary Department Of Health And Human Services MHC-Class II restricted melanoma antigens and their use in therapeutic methods
AU1394497A (en) * 1996-01-17 1997-08-11 Imperial College Innovations Limited Immunotherapy using cytotoxic t lymphocytes (ctl)
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
AU5066098A (en) * 1996-11-22 1998-06-10 Shiloov Medical Technologies Ltd. A whole blood/mitogen assay for the early detection of a subject with cancer and kit

Also Published As

Publication number Publication date
NO942660D0 (no) 1994-07-15
JPH07503134A (ja) 1995-04-06
EP0624189A4 (en) 1995-05-17
FI943422A (fi) 1994-07-19
NO942660L (no) 1994-09-16
KR950700402A (ko) 1995-01-16
EP0624189A1 (en) 1994-11-17
AU3435293A (en) 1993-08-03
WO1993014189A1 (en) 1993-07-22
CA2128424A1 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
FI945441A (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
FI931736A (fi) Biodegraderbart tgf-b-leveranssystem foer benregeneration
DK0389379T3 (da) Korset til tredimensionel reduktion af skolioser
FI943422A0 (fi) Menetelmä sytolyyttisen T-solujen prekursorien määrittämiseksi
ITMI921552A0 (it) Procedimento per la preparazione di glicerofosfolipidi
NO930574L (no) Fremgangsmaate for fremstilling av desfluran
NO176415C (no) Lyslist for nivåglass
NL194866B (nl) Werkwijze ter bereiding van oplosmiddelvrije polycarbonaten.
FI941397A0 (fi) Menetelmä metyyliformiaatin valmistamiseksi
IT8421149A1 (it) Procedimento migliorato per il disproporzionamento di clorosilani
FI952134A (fi) Menetelmä alkyykibentseenin valmistamiseksi
GB9105669D0 (en) Apparatus for the temporary storage of products
EP0558012A3 (en) Method for the manufacture of branched polysiloxane
FI911126A0 (fi) Organokupraattimenetelmä kefprotsilin valmistamiseksi
GB2270644B (en) Apparatus for the electrochemical machining of components
IT1243410B (it) Procedimento per la funzionalizzazione di trifluorometilbenzeni
FI901668A (fi) Menetelmä plasmiiniaktiivisuuden määrittämiseksi
ITMI922181A0 (it) Procedimento per la preparazione di perfluoro-2-metil-4-metossipentano
DK0569701T3 (da) Fremgangsmåde til fremstilling af 2-amino-5-methyl-pyridin
MX9100857A (es) Procedimiento para la purificacion de 4-acetoxiestireno
DK0599044T3 (da) Fremgangsmåde til fremstilling af chlorphenylphosphaner
MX24595A (es) Derivados de fenilimidazol y procedimiento para supreparacion.
ITBO920282A1 (it) Metodo per la realizzazione di sigarette con filtro
BG96440A (en) Method for the furification of 8-phycoerythrin
IT9020275A0 (it) Procedimento per la fabbricazione di 7-dimetilamino-6-demetil-6- deossitetraciclina

Legal Events

Date Code Title Description
FD Application lapsed